Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study
Swiss Medical Weekly · 25.01.2024 · 154 (1) · 3735
DOI: 10.57187/s.3735 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Swiss Medical Weekly, online erschienen am 25.01.2024. Verfasst von Michel Romanens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Risk Foundation (Varifo), Olten, Switzerland. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Coronary Artery Disease, Atherosclerosis, Myocardial Infarction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
AIMS: Many cardiovascular events occur in seemingly healthy individuals.We set out to assess the predictive value of atherosclerosis imaging in combination with cardiovascular risk calculators in subjects aged 40–65 years. METHODS: We compared PROCAM (PROspective CArdiovascular Münster study), SCORE (Systematic COronary Risk Evaluation) and SCORE2 with carotid ultrasound (total plaque area, TPA) in subjects without cardiovascular disease. In this prospective cohort study, follow-up was obtained by phone or mail from patients; or from clinical records, if needed. RESULTS: In 2842 subjects (mean age 50±8 years; 38% women), cardiovascular events occurred in 154 (5.4%) of them over an mean follow-up period of 5.9 (range 1–12) years, specifically: 41 cases of AMI (myocardial infarction), 16 strokes, 21 CABG (coronary artery bypass grafting), 41 PTCA (percutaneous transluminal coronary angioplasty) and 35 CAD (coronary artery disease). Mean PROCAM risk was 5±6%, mean SCORE risk was 1.3±1.6% and mean SCORE2 risk was 5±3%. Both for the primary outcome (major adverse cardiovascular events, MACEs, i.e. AMI + strokes) and the secondary outcome (atherosclerotic cardiovascular disease, ASCVD, i.e. MACEs + CABG + CAD + PTCA), hazards increased significantly for TPA tertiles and SCORE2 post-test risk between 6.7 to 12.8 after adjustment for risk factors (age, smoke, sex, systolic blood pressure, lipids, medication) and after adjustment for results from PROCAM, SCORE and SCORE2. Model performance was statistically improved regarding model fit in all models using TPA. Net reclassification improvement for SCORE2 with TPA post-test risk increased significantly by 24% for MACEs (p = 0.01) and 39% for ASCVD (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Vascular Risk Foundation (Varifo), Olten, Switzerland.
- BAD Gesundheitsvorsorge und Sicherheitstechnik GmbH, Bonn, Germany.
- Sanacare Centramed Medical Centre, Basel, Switzerland.
- Gesundheitsforen Leipzig, Leipzig, Germany.
- University Heart Centre, Cardiology, University Hospital Zurich, Zurich, Switzerland.
Zitieren
APA
Romanens, M., Adams, A., Wenger, M., Warmuth, W., & Sudano, I. (2024). Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study. Swiss Medical Weekly, 154(1), 3735. https://doi.org/10.57187/s.3735
Vancouver
Romanens M, Adams A, Wenger M, Warmuth W, Sudano I. Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study. Swiss Medical Weekly. 2024;154(1):3735. doi:10.57187/s.3735
BibTeX
@article{Romanens2024,
author = {Romanens, Michel and Adams, Ansgar and Wenger, Michel and Warmuth, Walter and Sudano, Isabella},
title = {Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study},
journal = {Swiss Medical Weekly},
year = {2024},
volume = {154},
number = {1},
pages = {3735},
doi = {10.57187/s.3735}
}
EUVIMED